Simon R Knight

Loading... 2 0 20 0 false
Credit Name
Simon R Knight
Full Name
Knight, Simon R
 
Department
 
Loading... 3 0 20 0 false

Publications

Refined By:
Author:  Scott, Andrew M
Subject:  Aged

Results 1-5 of 5 (Search time: 0.006 seconds).

Publication YearTitleAuthor(s)
11-Jul-2010Long-term survival of 42 patients with resected N2 non-small-cell lung cancer: the impact of 2-(18)F-fluoro-2-deoxy-D-glucose positron emission tomogram mediastinal staging.Barnett, Stephen A ; Baste, Jean-Marc; Murugappan, Kowsi; Tog, Check; Berlangieri, Salvatore U ; Scott, Andrew M ; Seevanayagam, Siven ; Knight, Simon R 
228-Mar-2009Prognostic value of 18F-FDG PET/CT in patients with malignant pleural mesothelioma.Lee, S T; Ghanem, M; Herbertson, R A; Berlangieri, Salvatore U ; Byrne, Amanda J; Tabone, K; Mitchell, Paul L R ; Knight, Simon R ; Feigen, Malcolm; Scott, Andrew M 
321-May-2007Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules.Lee, S T; Berlangieri, Salvatore U ; Poon, A M T; Mitchell, Paul L R ; Pathmaraj, K ; Tabone, K; Byrne, Amanda J; O'Keefe, Graeme J; Knight, Simon R ; Clarke, C Peter; Scott, Andrew M 
41-Dec-2006Lack of correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in non-small cell lung cancer assessed by 18F-Fluoromisonidazole and 18F-FDG PET.Cherk, Martin H; Foo, Serene S; Poon, Aurora M T ; Knight, Simon R ; Murone, Carmel ; Papenfuss, Anthony T; Sachinidis, John I; Saunder, Timothy H C; O'Keefe, Graeme J; Scott, Andrew M 
55-May-2005Positron emission tomography with selected mediastinoscopy compared to routine mediastinoscopy offers cost and clinical outcome benefits for pre-operative staging of non-small cell lung cancer.Yap, Kelvin K; Byrne, Amanda J; Berlangieri, Salvatore U ; Poon, Aurora M T ; Mitchell, Paul L R ; Knight, Simon R ; Clarke, Peter C; Harris, Anthony H; Tauro, Andrew; Rowe, Christopher C ; Scott, Andrew M